男性乳腺癌合并抗合成酶综合征相关间质性肺疾病一例
本文报道1例58岁男性乳腺癌患者,术前评估诊断抗合成酶综合征相关间质性肺疾病,肌炎抗体谱抗EJ及抗Ro52抗体阳性。经多学科评估后针对乳腺癌治疗,术后1个月间质性肺炎自发好转,术后7个月进一步好转且抗EJ抗体转阴、抗Ro52抗体滴度下降,支持肿瘤相关肌炎相关间质性肺疾病诊断。
要点
- 合并恶性肿瘤的间质性肺疾病患者应注意筛查肌炎抗体谱。
- 管理需权衡恶性肿瘤与肌炎相关间质性肺疾病的治疗获益与风险。
- 建议密切随访,综合制定治疗方案。
核心结论
- 本例支持肿瘤相关肌炎相关间质性肺疾病的诊断,提示对合并恶性肿瘤的间质性肺疾病患者应筛查肌炎抗体谱并密切随访。
研究设计与样本
- 个案报道:1例58岁男性乳腺癌患者,术前评估发现抗合成酶综合征相关间质性肺疾病,肌炎抗体谱抗EJ及抗Ro52抗体阳性。
主要发现
- 术后1个月复查胸部CT示间质性肺炎自发好转,术后7个月进一步好转。
- 术后7个月血清抗EJ抗体转阴、抗Ro52抗体滴度下降。
关键数值与推荐
- 炎性肌病患者合并恶性肿瘤风险高于普通人群,二者发病间隔<3年的病例称为肿瘤相关性肌炎。
临床怎么用
- 对间质性肺疾病合并恶性肿瘤患者筛查肌炎抗体谱有助于诊断。
- 治疗需经外科、呼吸科、麻醉科等多学科评估,权衡肿瘤与肌炎相关间质性肺疾病的获益与风险,并密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with inflammatory myopathy face an increased risk of cancer compared to the general population. Cases in which malignancy develops within three years of a diagnosis of inflammatory myopathy are recognized as cancer-associated myositis. Anti-synthetase syndrome (ASS) is a unique type of inflammatory myopathy, with a high prevalence of interstitial lung disease (ILD). We presented a case of a 58-year-old male with a breast lump. The core needle biopsy confirmed the diagnosis of breast cancer, and surgery was arranged. However, during the preoperative evaluation, the patient was found to have ASS-associated ILD. The myositis autoantibody panel showed positivity of anti-EJ and anti-Ro52 antibodies. After assessments by the surgeon, pulmonologist and anesthesiologist, the patient underwent surgical therapy. One month after the surgery, a repeat chest CT scan showed spontaneous improvement of ILD. The patient then underwent adjuvant chemotherapy, followed by radiation therapy and endocrine therapy. He remained in good condition, and the chest CT scan repeated in the seventh month after surgery revealed further remission of ILD. Moreover, his serum anti-EJ antibody turned negative and the titer of anti-Ro52 antibody decreased. These findings support the diagnosis of tumor-associated myositis-associated ILD. For ILD patients with concurrent malignancy, it is helpful to screen for myositis autoantibody panel. Potential benefits and risks of treatments for both malignancy and myositis-associated ILD should be cautiously balanced during the management of these patients, and close follow-up is recommended. 炎性肌病患者合并恶性肿瘤的风险高于普通人群,二者发病间隔<3年的病例可称为肿瘤相关性肌炎。抗合成酶综合征是一种特殊类型的炎性肌病,容易并发间质性肺疾病。本文报道1例58岁男性患者,以发现乳腺肿物起病,穿刺活检后诊断乳腺癌拟行手术治疗,术前评估诊断抗合成酶综合征相关间质性肺疾病(肌炎抗体谱为抗EJ抗体及抗Ro52抗体阳性)。经乳腺外科、呼吸内科、麻醉科等科室共同评估后,积极针对乳腺癌开展相关治疗,术后1个月评估间质性肺炎呈自发好转趋势,辅助化疗序贯放疗、内分泌治疗后整体病情稳定,术后7个月评估间质性肺炎进一步好转,且抗EJ抗体转阴、抗Ro52抗体滴度下降,支持肿瘤相关肌炎相关间质性肺疾病的诊断。对于合并恶性肿瘤的间质性肺疾病患者应注意筛查肌炎抗体谱,在患者管理时应注意权衡恶性肿瘤、肌炎相关间质性肺疾病的治疗获益与风险,综合制定治疗方案,并密切随访。.
引用
- Chen RX, Shi YJ, Li ZY, et al. [Anti-synthetase syndrome-associated interstitial lung disease in a male breast cancer patient: a case report]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 41218866. doi:10.3760/cma.j.cn112147-20250505-00245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。